Entera Bio Ltd.
ENTX
|
$2.22
-3.06%
-7.01%
210K
|
Health Technology
(0.0% 1d) (62.4% 1m) (163.2% 1y) (0.0% 2d) (0.0% 3d) (-23.2% 7d) (-19.5% volume)
Earnings Calendar: 2022-11-09
Market Cap: $ 78,768,577
http://www.enterabio.com
Sec Filling | Patents | 24 employees
(IL) Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of orally delivered large molecule therapeutics. It develops an oral formulation of parathyroid hormone. The company was founded on June 1, 2010 and is headquartered in Jerusalem, Israel.
hormone israel osteoporosis eb613 bone
add to watch list Paper trade email alert is off
Press-releases
Entera Bio Announces Publication of Oral PTH(1-34) Peptide Tablets (EB613) Phase 2 Trial Data in the Journal of Bone and Mineral Research
Published: 2024-04-08 (Crawled : 12:30) - globenewswire.com
ENTX | $2.22 -3.06% -7.01% 210K
|
Health Technology
|
| O: 2.3%
H: 1.25%
C: -2.5%
eb613 publication research bone trial
Entera Bio Announces Key Regulatory Milestone for Oral PTH(1-34) Peptide (EB613) Phase 3 Program: FDA Ruling on Qualifying BMD as a Surrogate Endpoint for Osteoporosis Drugs is Expected Within 10 Months
Published: 2024-03-26 (Crawled : 12:30) - globenewswire.com
ENTX | $2.22 -3.06% -7.01% 210K
|
Health Technology
|
| O: 12.18%
H: 0.0%
C: -11.43%
eb613 fda expected osteoporosis key milestone
Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome
Published: 2024-03-20 (Crawled : 12:00) - globenewswire.com
OPK | $1.25 3.31% 3.59% 3.5M
|
Health Technology
|
| O: 1.08%
H: 5.01%
C: 1.17%
ENTX | $2.22 -3.06% -7.01% 210K
|
Health Technology
|
| O: 0.69%
H: 8.45%
C: 7.04%
treatment
Entera Bio Announces Full Year 2023 Financial Results and Provides Business Updates
Published: 2024-03-08 (Crawled : 21:00) - globenewswire.com
ENTX | $2.22 -3.06% -7.01% 210K
|
Health Technology
| Email alert
Add to watchlist
business year financial results
Entera Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement
Published: 2024-03-04 (Crawled : 13:30) - globenewswire.com
ENTX | $2.22 -3.06% -7.01% 210K
|
Health Technology
|
| O: 3.47%
H: 17.45%
C: 15.44%
nasdaq
Entera Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
Published: 2024-01-30 (Crawled : 13:30) - globenewswire.com
ENTX | $2.22 -3.06% -7.01% 210K
|
Health Technology
|
| O: -0.83%
H: 0.28%
C: -1.14%
conference life sciences
Entera Bio Receives Extension from Nasdaq to Regain Compliance with Minimum Bid Price Rule
Published: 2024-01-03 (Crawled : 13:00) - globenewswire.com
ENTX | $2.22 -3.06% -7.01% 210K
|
Health Technology
|
| O: 0.78%
H: 0.0%
C: -2.29%
nasdaq extension
Entera Bio Announces Closing of Private Placement - Extends Cash Runway into 2025
Published: 2023-12-26 (Crawled : 13:00) - globenewswire.com
ENTX | $2.22 -3.06% -7.01% 210K
|
Health Technology
|
| O: 3.08%
H: 5.97%
C: -2.58%
Interim Results from Ongoing Clinical Study Confirm EB613 Optimized Profile for Osteoporosis Treatment and Potential for Entera’s Next Generation Oral Peptide Platform
Published: 2023-11-29 (Crawled : 13:30) - globenewswire.com
ENTX | $2.22 -3.06% -7.01% 210K
|
Health Technology
|
| O: 2.55%
H: 1.42%
C: -2.88%
eb613 osteoporosis treatment ongoing potential results study platform
Entera Bio Reports Q3 2023 Financial Results, Highlights Transformational Steps and Unveils Vision as Premier Oral Peptide Company with Five Potential Programs in Development
Published: 2023-11-14 (Crawled : 12:30) - globenewswire.com
OPK | $1.25 3.31% 3.59% 3.5M
|
Health Technology
|
| O: 2.34%
H: 6.87%
C: 6.11%
ENTX | $2.22 -3.06% -7.01% 210K
|
Health Technology
|
| O: 0.0%
H: 3.0%
C: 2.86%
company financial potential
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 57% | 43% |
Top 10 Gainers
INVO | $1.82 139.47% 56.82% 220M
|
Health Technology
SINT | $0.0373 62.88% 37.26% 460M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.66 46.37% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 600K
|
Manufacturing
TCON | $2.29 33.92% 26.61% 1.8M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
SRFM 4 | $0.3859 -12.3% 23.84% 660K
|
n/a
KZIA | $0.3442 18.28% 23.42% 290K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
Last 48 Hours Insiders Buying
IZEA | $2.53 1.2% -2.4% 8.7K
|
Technology Services
|
00:00
RKT P 383 | $11.38 -0.52% 1.58% 1.4M
|
Finance
|
22:30
CTRN P 18090 | $22.37 -1.41% -1.02% 55K
|
Retail Trade
|
22:00
BRN P 10650 | $2.79 2.2% 0.0% 35K
|
Energy Minerals
|
21:00
NEOG P 10000 | $12.14 -0.16% -0.16% 3.1M
|
Health Technology
|
16:30
RMCF | $3.53 -3.16% -3.85% 3.8K
|
Consumer Non-Durables
|
20:10